Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of finding ways to analyze and utilize this data to help patients.
The impact of social determinants of health
Social determinants of health are the conditions where patients live, learn, work and play. Key SDOH areas include employment, education, crime and incarceration, access to healthcare, pollution, and food insecurity. SDOH data sets are large and complex, including census data, ICD-10 Z-codes and consumer behavior data.
Analyzing and predicting which social determinants are most likely to put patients at risk can help healthcare organizations intervene effectively to improve outcomes for individual patients.
How AI delivers value from SDOH data
Artificial intelligence (AI) is designed to work with large and complex data sets –– for example, AllazoHealth’s AI engine has has access to a comprehensive data set from over 12 million lives, including real world data from payer, provider and retail claims, social determinants of health, and patient interventions.
AI can unlock the value in SDOH data. It can identify patients who struggle with health issues associated with SDOH. AI can customize targeted interventions that will help these patients better manage their health, while maximizing the use of resources.
Recently, a study published in the American Journal of Managed Care found that AI accurately predicted inpatient and emergency department utilization with the use of only publicly available SDOH data such as gender, age, race, and address. The study also found that local air quality and income were more important health predictors than age, gender, or ethnicity.
Why access to SDOH data is not enough
It’s not enough to have access to SDOH data — you also need a team that understands the unique complexity of healthcare data. AllazoHealth’s sole focus is utilizing artificial intelligence to make a positive impact on healthcare outcomes. Our programs with payers include gap in care, adherence, and quality measures.
And AllazoHealth is the only healthcare AI adherence company to have run a randomized control trial. Partnering with Blue Cross Blue Shield of North Carolina, we demonstrated a 5.5 times uplift in adherence compared with traditional programs.
